TY - JOUR
T1 - Prevalence of hyperhomocyst(e)inemia in patients with peripheral arterial occlusive disease
AU - Malinow, M. R.
AU - Kang, S. S.
AU - Taylor, L. M.
AU - Wong, P. W.K.
AU - Coull, B.
AU - Inahara, T.
AU - Mukerjee, D.
AU - Sexton, G.
AU - Upson, B.
PY - 1989
Y1 - 1989
N2 - A micromethod adapted for automated determinations was uesed to measure basal plasma levels of homocyst(e)ine [H(e)]. These levels included the sum of free and bound forms of homocysteine, its disulfide oxidation product, homocystine, and the homocysteine-cysteine-mixed disulfide. Two groups of subjects were studied: apparently healthy individuals (n = 103) and patients with peripheral arterial occlusive disease (PAOD) (n = 47). Because age in PAOD patients was higher than in control subjects, the control subjects were subdivided into younger and older groups (aged 60 years or less and more than 60 years, respectively). The H(e) levels in the younger groups were 11.18 ± 3.58 (mean ± SD, expressed as homocysteine) and 8.58 ± 2.82 nmol/ml in men and women, respectively; in the older groups, the levels were 10.74 ± 2.16 and 9.04 ± 2.16 nmol/ml in men and women, respectively. There was a positive correlation of H(e) levels with age in the younger control women (r = 0.373; p < 0.02); no significant correlations were present in the other three control groups. Levels of H(e) in PAOD patients (15.44 ± 5.76 and 17.04 ± 8.26 nmol/ml in men and women, respectively) were significantly higher than those indicated above in the older controls. Next, the PAOD patients were assigned to two subgroups: 1) those with normal levels of H(e) (within two standard deviations of the mean of the control values) and 2) those with elevated levels of H(e). Age, cholesterolemia, and the prevalnece of smoking and diabetes were similar in both subgroups. These results suggest that elevated plasma H(e) is an independent risk factor for arterial occlusive disease.
AB - A micromethod adapted for automated determinations was uesed to measure basal plasma levels of homocyst(e)ine [H(e)]. These levels included the sum of free and bound forms of homocysteine, its disulfide oxidation product, homocystine, and the homocysteine-cysteine-mixed disulfide. Two groups of subjects were studied: apparently healthy individuals (n = 103) and patients with peripheral arterial occlusive disease (PAOD) (n = 47). Because age in PAOD patients was higher than in control subjects, the control subjects were subdivided into younger and older groups (aged 60 years or less and more than 60 years, respectively). The H(e) levels in the younger groups were 11.18 ± 3.58 (mean ± SD, expressed as homocysteine) and 8.58 ± 2.82 nmol/ml in men and women, respectively; in the older groups, the levels were 10.74 ± 2.16 and 9.04 ± 2.16 nmol/ml in men and women, respectively. There was a positive correlation of H(e) levels with age in the younger control women (r = 0.373; p < 0.02); no significant correlations were present in the other three control groups. Levels of H(e) in PAOD patients (15.44 ± 5.76 and 17.04 ± 8.26 nmol/ml in men and women, respectively) were significantly higher than those indicated above in the older controls. Next, the PAOD patients were assigned to two subgroups: 1) those with normal levels of H(e) (within two standard deviations of the mean of the control values) and 2) those with elevated levels of H(e). Age, cholesterolemia, and the prevalnece of smoking and diabetes were similar in both subgroups. These results suggest that elevated plasma H(e) is an independent risk factor for arterial occlusive disease.
UR - http://www.scopus.com/inward/record.url?scp=0024391453&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0024391453&partnerID=8YFLogxK
U2 - 10.1161/01.CIR.79.6.1180
DO - 10.1161/01.CIR.79.6.1180
M3 - Article
C2 - 2785871
AN - SCOPUS:0024391453
SN - 0009-7322
VL - 79
SP - 1180
EP - 1188
JO - Circulation
JF - Circulation
IS - 6
ER -